03/27/2025
4:08 PM | Chromocell Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/03/2025
6:00 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
12:09 PM | Chromocell Therapeutics (Subject)
Ikarian Capital, LLC (Filed by)
| Form SCHEDULE 13G | |
01/15/2025
4:27 PM | Alexandra Wood Inc. (0002052171) (Filed by)
Chromocell Therapeutics (Subject)
| Form SCHEDULE 13G | |
12/19/2024
11:15 PM | Chromocell Therapeutics (Filer)
| Form EFFECT | |
12/11/2024
3:06 PM | Chromocell Therapeutics (Filer)
| Form POS AM | |
12/02/2024
11:15 PM | Chromocell Therapeutics (Filer)
| Form EFFECT | |
11/22/2024
3:30 PM | Chromocell Therapeutics (Filer)
| Form POS AM | |
11/21/2024
8:00 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
4:03 PM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
3:19 PM | Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CHRO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Chromocell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
11/15/2024
3:20 PM | Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
3:22 PM | Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:19 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
11/13/2024
4:14 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
11/13/2024
3:30 PM | Chromocell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2024
3:05 PM | 3i, LP (Filed by)
Chromocell Therapeutics (Subject)
| Form SC 13G/A | |
10/24/2024
7:30 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/26/2024
4:08 PM | Chromocell Therapeutics (Filer)
| Form DEF 14A | |
09/16/2024
3:55 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:56 PM | Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
4:35 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
4:30 PM | Chromocell Therapeutics (Filer)
| Form PRE 14A | |
08/13/2024
4:23 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
4:19 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
08/13/2024
3:31 PM | Chromocell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2024
3:50 PM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
11:15 PM | Chromocell Therapeutics (Filer)
| Form EFFECT | |
08/06/2024
3:49 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
07/29/2024
8:06 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
8:07 AM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
07/29/2024
8:08 AM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
07/29/2024
8:15 AM | Chromocell Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
07/02/2024
4:15 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 3/A | |
07/02/2024
4:17 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:05 PM | Chromocell Therapeutics (Issuer)
Lang Eric (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:06 PM | Chromocell Therapeutics (Issuer)
Simmons Chia-Lin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:07 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4/A | |
06/18/2024
7:00 PM | Chromocell Therapeutics (Issuer)
Davis Todd C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:01 PM | Chromocell Therapeutics (Issuer)
Francis Knuettel II (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
7:02 PM | Chromocell Therapeutics (Issuer)
Malamut Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Musk’s real agenda in D.C. (Ad) In this urgent exposé, you’ll discover…
How Elon and Donald Trump are quietly drawing a radical new map of America… Here’s the full story. |
06/18/2024
7:03 PM | Chromocell Therapeutics (Issuer)
Friedberg Ezra M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
3:21 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
05/15/2024
3:15 PM | Chromocell Therapeutics (Filer)
| Form 424B3 | |
04/16/2024
3:48 PM | Chromocell Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/12/2024
6:22 PM | Chromocell Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/09/2024
7:30 AM | Chromocell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
8:00 AM | Chromocell Therapeutics (Filer)
| Form NT 10-K | |
